We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMH
1276
UMH Properties
UMH
$1.39B
$16.4M ﹤0.01%
666,649
+72,929
+12% +$1.75M
RRC icon
1277
Range Resources
RRC
$9.39B
$16.4M ﹤0.01%
538,296
+28,178
+6% +$643K
THRX
1278
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$16.3M ﹤0.01%
1,436,616
+137,129
+11% +$1.47M
SNA icon
1279
Snap-on
SNA
$21.1B
$16.3M ﹤0.01%
79,162
-329,004
-81% -$69.4M
MMS icon
1280
Maximus
MMS
$2.94B
$16.2M ﹤0.01%
215,738
-52,868
-20% -$4.05M
ZION icon
1281
Zions Bancorporation
ZION
$10.5B
$16M ﹤0.01%
244,360
+13,948
+6% +$954K
OSH
1282
DELISTED
Oak Street Health, Inc.
OSH
$15.9M ﹤0.01%
591,975
+28,213
+5% +$595K
JBLU icon
1283
JetBlue
JBLU
$2.19B
$15.9M ﹤0.01%
1,063,168
+34,883
+3% +$505K
DT icon
1284
Dynatrace
DT
$14.3B
$15.9M ﹤0.01%
337,333
+67,875
+25% +$3.2M
DAWN
1285
DELISTED
Day One Biopharmaceuticals
DAWN
$15.7M ﹤0.01%
1,585,741
+4,763
+0.3% +$62.9K
INN
1286
Summit Hotel Properties
INN
$656M
$15.7M ﹤0.01%
1,571,488
-619,582
-28% -$6.09M
LUXE
1287
LuxExperience B.V.
LUXE
$1.09B
$15.5M ﹤0.01%
1,266,704
-1,247,388
-50% -$18.9M
PEGA icon
1288
Pegasystems
PEGA
$5.15B
$15.5M ﹤0.01%
384,092
-137,746
-26% -$6.18M
UHS icon
1289
Universal Health Services
UHS
$10.2B
$15.5M ﹤0.01%
106,838
-10,136
-9% -$1.4M
HAS icon
1290
Hasbro
HAS
$13.4B
$15.4M ﹤0.01%
188,111
-12,294
-6% -$1.15M
QSR icon
1291
Restaurant Brands International
QSR
$26.1B
$15.4M ﹤0.01%
262,962
+5,500
+2% +$313K
OMF icon
1292
OneMain Financial
OMF
$7.44B
$15.4M ﹤0.01%
323,819
+292,227
+925% +$14.6M
LNC icon
1293
Lincoln National
LNC
$8.44B
$15.3M ﹤0.01%
234,197
-20,630
-8% -$1.41M
DUOL icon
1294
Duolingo
DUOL
$6.74B
$15.2M ﹤0.01%
159,561
-33,251
-17% -$3M
AGFS
1295
DELISTED
AgroFresh Solutions Inc
AGFS
$15M ﹤0.01%
7,911,072
-71,095
-0.9% -$143K
SGA icon
1296
Saga Communications
SGA
$64.6M
$15M ﹤0.01%
657,258
FRSH icon
1297
Freshworks
FRSH
$3.51B
$15M ﹤0.01%
+837,129
New +$17M
LUMN icon
1298
Lumen
LUMN
$6.6B
$14.9M ﹤0.01%
1,323,494
-50,841
-4% -$582K
WHR icon
1299
Whirlpool
WHR
$2.79B
$14.8M ﹤0.01%
85,649
-7,232
-8% -$1.47M
TPR icon
1300
Tapestry
TPR
$25.9B
$14.6M ﹤0.01%
392,113
-30,344
-7% -$1.16M

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.